Aviva’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $150M | Buy |
1,183,858
+9,282
| +0.8% | +$1.22M | 0.22% | 81 |
|
|
2026
Q1 | $164M | Buy |
1,174,576
+17,838
| +2% | +$2.5M | 0.27% | 66 |
|
|
2025
Q4 | $142M | Buy |
1,156,738
+59,782
| +5% | +$7.27M | 0.24% | 79 |
|
|
2025
Q3 | $122M | Buy |
1,096,956
+56,151
| +5% | +$6.38M | 0.22% | 89 |
|
|
2025
Q2 | $115M | Sell |
1,040,805
-159,954
| -13% | -$17M | 0.24% | 85 |
|
|
2025
Q1 | $135M | Buy |
1,200,759
+106,212
| +10% | +$11M | 0.32% | 55 |
|
|
2024
Q4 | $101M | Sell |
1,094,547
-54,085
| -5% | -$4.87M | 0.26% | 74 |
|
|
2024
Q3 | $96.3M | Buy |
1,148,632
+2,308
| +0.2% | +$176K | 0.25% | 80 |
|
|
2024
Q2 | $78.6M | Buy |
1,146,324
+240,384
| +27% | +$16M | 0.22% | 89 |
|
|
2024
Q1 | $66.4M | Buy |
905,940
+39,455
| +5% | +$3.03M | 0.22% | 89 |
|
|
2023
Q4 | $70.2M | Buy |
866,485
+66,226
| +8% | +$5.15M | 0.25% | 78 |
|
|
2023
Q3 | $60M | Buy |
800,259
+13,074
| +2% | +$1.01M | 0.25% | 72 |
|
|
2023
Q2 | $60.7M | Buy |
787,185
+68,380
| +10% | +$5.45M | 0.25% | 76 |
|
|
2023
Q1 | $59.6M | Buy |
718,805
+95,443
| +15% | +$7.91M | 0.27% | 63 |
|
|
2022
Q4 | $53.5M | Buy |
623,362
+105,121
| +20% | +$8.32M | 0.26% | 69 |
|
|
2022
Q3 | $32M | Sell |
518,241
-19,547
| -4% | -$1.23M | 0.18% | 121 |
|
|
2022
Q2 | $33.2M | Buy |
537,788
+117,295
| +28% | +$7.26M | 0.18% | 120 |
|
|
2022
Q1 | $25M | Buy |
420,493
+19,418
| +5% | +$1.24M | 0.13% | 181 |
|
|
2021
Q4 | $29.1M | Sell |
401,075
-54,237
| -12% | -$3.74M | 0.12% | 166 |
|
|
2021
Q3 | $31.8M | Buy |
455,312
+8,447
| +2% | +$593K | 0.14% | 147 |
|
|
2021
Q2 | $30.8M | Buy |
446,865
+27,639
| +7% | +$1.85M | 0.14% | 160 |
|
|
2021
Q1 | $27.1M | Sell |
419,226
-383
| -0.1% | -$24.7K | 0.13% | 158 |
|
|
2020
Q4 | $24.4M | Buy |
419,609
+14,026
| +3% | +$846K | 0.13% | 160 |
|
|
2020
Q3 | $25.6M | Sell |
405,583
-14,141
| -3% | -$981K | 0.15% | 123 |
|
|
2020
Q2 | $32.3M | Sell |
419,724
-28,878
| -6% | -$2.21M | 0.2% | 100 |
|
|
2020
Q1 | $33.5M | Buy |
448,602
+270
| +0.1% | +$18.7K | 0.25% | 87 |
|
|
2019
Q4 | $29.1M | Sell |
448,332
-2,361
| -0.5% | -$154K | 0.18% | 114 |
|
|
2019
Q3 | $28.6M | Sell |
450,693
-133,845
| -23% | -$8.75M | 0.19% | 113 |
|
|
2019
Q2 | $39.5M | Sell |
584,538
-12,161
| -2% | -$800K | 0.27% | 82 |
|
|
2019
Q1 | $38.8M | Sell |
596,699
-5,423
| -0.9% | -$360K | 0.26% | 93 |
|
|
2018
Q4 | $37.7M | Sell |
602,122
-138,139
| -19% | -$9.66M | 0.28% | 91 |
|
|
2018
Q3 | $57.2M | Sell |
740,261
-26,254
| -3% | -$1.98M | 0.31% | 83 |
|
|
2018
Q2 | $54.3M | Sell |
766,515
-10,705
| -1% | -$756K | 0.32% | 78 |
|
|
2018
Q1 | $58.6M | Sell |
777,220
-62,528
| -7% | -$4.97M | 0.36% | 70 |
|
|
2017
Q4 | $60.2M | Sell |
839,748
-104,966
| -11% | -$7.97M | 0.34% | 69 |
|
|
2017
Q3 | $76.5M | Buy |
944,714
+12,850
| +1% | +$983K | 0.41% | 54 |
|
|
2017
Q2 | $66M | Buy |
931,864
+4,340
| +0.5% | +$289K | 0.37% | 60 |
|
|
2017
Q1 | $63M | Sell |
927,524
-34,573
| -4% | -$2.43M | 0.36% | 63 |
|
|
2016
Q4 | $68.9M | Sell |
962,097
-76,794
| -7% | -$5.71M | 0.41% | 53 |
|
|
2016
Q3 | $82.2M | Buy |
1,038,891
+141,685
| +16% | +$11.5M | 0.51% | 43 |
|
|
2016
Q2 | $74.8M | Sell |
897,206
-45,473
| -5% | -$4.04M | 0.51% | 46 |
|
|
2016
Q1 | $86.6M | Sell |
942,679
-189,414
| -17% | -$17.1M | 0.64% | 33 |
|
|
2015
Q4 | $115M | Buy |
1,132,093
+134,385
| +13% | +$14M | 0.87% | 17 |
|
|
2015
Q3 | $98M | Sell |
997,708
-82,792
| -8% | -$9.2M | 0.81% | 17 |
|
|
2015
Q2 | $127M | Sell |
1,080,500
-63,967
| -6% | -$6.99M | 0.89% | 14 |
|
|
2015
Q1 | $112M | Buy |
1,144,467
+351,918
| +44% | +$35.7M | 0.77% | 20 |
|
|
2014
Q4 | $74.7M | Buy |
792,549
+55,165
| +7% | +$5.71M | 0.58% | 35 |
|
|
2014
Q3 | $78.5M | Sell |
737,384
-1,651
| -0.2% | -$162K | 0.62% | 31 |
|
|
2014
Q2 | $61.3M | Buy |
739,035
+400
| +0.1% | +$31.1K | 0.47% | 47 |
|
|
2014
Q1 | $52.3M | Sell |
738,635
-57,941
| -7% | -$4.54M | 0.42% | 54 |
|
|
2013
Q4 | $59.9M | Sell |
796,576
-157,261
| -16% | -$11M | 0.5% | 45 |
|
|
2013
Q3 | $59.9M | Buy |
953,837
+90,388
| +10% | +$5.4M | 0.53% | 41 |
|
|
2013
Q2 | $44.2M | Buy |
+863,449
| New | +$45M | 0.45% | 48 |
|
Other funds holding GILD
Aviva's GILD Position: Q2 2026 in Review
Aviva increased its Gilead Sciences (GILD) stake by 0.79% in Q2 2026, buying an estimated $1.22M and bringing the position to 1,183,858 shares worth $150M. The position accounts for 0.22% of the portfolio, ranked #81.
Aviva first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $164M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Aviva held 1,183,858 shares of Gilead Sciences worth $150M as of Q2 2026.
- Aviva bought 9,282 Gilead Sciences shares in Q2 2026, an estimated $1.22M.
- Gilead Sciences made up 0.22% of Aviva's portfolio in Q2 2026, its #81 holding.
- Aviva first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Aviva's Gilead Sciences position peaked at $164M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.